HEALTHCARE PRODUCTS
SunBio PEGylation technology and PEG products have played a crucial role in many successfully
marketed biosimilar, biopharmaceutical and medical devices products worldwide.
The healthcare products under development at SunBio are listed in the table.
| Category | Product/Candidate | Status | Launch |
|---|---|---|---|
| Biosimilar | PEG-filgrastim Biosimilar | Marketed | 2018 EU 2018 Canada 2008 India |
| PEG-EPO Biosimilar | Preclinical | 2023 (forecast) | |
| Medical Device | Xerostomia Treatment (MucoPEG) |
2019.11 FDA Approved | 2020(forecast) |
| Viscosupplement for Arthritic Knee (SynoGEL) |
2021 FDA filing planned | 2022 (forecast) | |
| Biopharmaceutical | Brain Stroke Treatment (SB1) | Preclinical | 2025 (forecast) |
| Diabetic Retinopathy Treatment (SB2) | Preclinical | 2025 (forecast) | |
| Anemia Treatment (SB7) | Preclinical | 2028 (forecast) | |
| PEG Product | PEG Derivatives Manufacture and Sales | Marketed | Worldwide |